Common epilepsy drug disrupts early brain growth in human organoids after 30-day exposure

A study from several German institutions reveals that the epilepsy drug valproate disrupts early brain development in human brain organoids after 30 days of exposure. These findings highlight the drug's potential risk to fetal brain development and open new paths for research to mitigate such effects during pregnancy.